Humana Q4 Loss Narrows to $180M but 2026 Expense Ratio Guidance Spurs 6% Drop
Humana reported a $180 million Q4 net loss, beating analysts’ forecasted $250 million loss, with its combined medical expense ratio improving by 150 basis points to 85.2%. Despite the narrower loss, Humana shares fell 6% premarket after management projected the 2026 medical expense ratio rising to 87.5%.
1. Q4 Results
Humana posted a fourth-quarter net loss of $180 million, narrower than the $250 million analysts had expected, driven by improved underwriting performance and lower-than-estimated medical costs.
2. Expense Ratio Improvement
The company’s combined medical expense ratio fell to 85.2%, down 150 basis points year-over-year, reflecting lower claims severity and better network negotiation outcomes.
3. 2026 Guidance and Market Reaction
Management forecast a rise in the 2026 medical expense ratio to 87.5%, triggering a 6% premarket share decline as investors weighed margin compression risks.